Recombinant human insulin-like growth factor-I in ALS: description of a double-blind, placebo-controlled study. North American ALS/IGF-I Study Group

Neurology. 1996 Oct;47(4 Suppl 2):S93-4; discussion S94-5. doi: 10.1212/wnl.47.4_suppl_2.93s.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Double-Blind Method
  • Female
  • Humans
  • Insulin-Like Growth Factor I / therapeutic use*
  • Male

Substances

  • Insulin-Like Growth Factor I